MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-75-0022076
Nordic Pharmaceuticals Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.21 Cr
▼ 10% YoY
Net profit · FY 2025
₹3.37 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹6.85 Lakh
EBITDA margin 5.7%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹11.54 Lakh
Issued & subscribed
Open charges
₹46.99 Lakh
Secured borrowings
Company age
29 yrs
Est. 1997
Directors on board
4
As per MCA filings
About Nordic Pharmaceuticals Limited
Data last updated:
Nordic Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 September 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1997PLC089698. Its GSTIN is 09AACCN3948D1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹11.54 Lakh. It is led by directors including Kusum Poddar and Banwari Lal Poddar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nordeic House D 318 Avantika Sector I Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹3.37 Lakh (net margin 2.8%) and EBITDA of ₹6.85 Lakh (EBITDA margin 5.7%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 8% over five years.
The company is associated with 1 brand: Nordic Pharma Group. As per MCA filings, the company has open charges of ₹46.99 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
Nordic Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0022076). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nordicpharmagroup.com.
Company details
CIN U24231DL1997PLC089698
Registration Number 089698
Incorporation Date 16 September 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0022076
Recognitions & Rankings of Nordic Pharmaceuticals
Contact details
Nordic Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its website is nordicpharmagroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNordeic House D 318 Avantika Sector I Rohini, New Delhi, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nordic Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Nordic Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nordic Pharmaceuticals operates one associated brand: Nordic Pharma Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of branded generics and a range of OTC products | nordicpharmagroup.com |
Business activity
The main business activity of Nordic Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nordic Pharmaceuticals Limited, buy the company report.
Financials of Nordic Pharmaceuticals Limited
FY 2025 filings availableNordic Pharmaceuticals Limited reported revenue of ₹1.21 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹1.21 Cr ▼ 10%
Net profit · FY 2025
₹3.37 Lakh margin 2.8%
EBITDA · FY 2025
₹6.85 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 13%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 6%
5 years · compounded
▲ 2%
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 10% fall in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nordic Pharmaceuticals Limited, buy the company report.
Board of directors of Nordic Pharmaceuticals Limited
Nordic Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kusum Poddar Also directs: Nordic Formulations Private Limited, Alaknanda Cruiseline Limited | Director | 30 Mar 2015 | 11 Years 7 Months | Current |
| Banwari Lal Poddar Also directs: Nordic Formulations Private Limited | Director | 16 Sep 1997 | 29 Years 1 Months | Current |
| Manoj Kumar Poddar | Director | 16 Sep 1997 | 29 Years 1 Months | Current |
| Manish Poddar | Director | 16 Sep 1997 | 29 Years 1 Months | Current |
Peer comparison
Nordic Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mandlive Healthcare Private Limited | ₹1.21 Cr (FY 2025) | 1.0% | Chandigarh, India | |||
| Rachit Remedies Private Limited | ₹1.21 Cr (FY 2025) | 0.0% | Patna, Bihar, India | |||
| B2s Pharma Private Limited | ₹1.21 Cr (FY 2022) | 54.0% | Kolkata, West Bengal, India | |||
| Nordic Pharmaceuticals Limitedthis company | ₹1.21 Cr (FY 2025) | ₹3.37 Lakh | 2.8% | -10.0% | New Delhi, Delhi, India | |
| Levitas Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2018) | 14.0% | Ernakulam, Kerala, India | |||
| HP Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2025) | 1.0% | Saptapur, Karnataka, India |
To see the full peer comparison of Nordic Pharmaceuticals Limited, buy the company report.
Auditor
Nordic Pharmaceuticals Limited is audited by S. RANJAN & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. RANJAN & CO. | FY 2022 | 005222C |
Shareholding
The shareholding of Nordic Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nordic Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹46.99 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2014 | 10510423 | Bank of India | ₹6.99 Lakh | Open | |
| 01 Feb 1999 | 90035047 | Bank of India | ₹40 Lakh | Open |
To see the full charge records of Nordic Pharmaceuticals Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Nordic Pharmaceuticals Limited has 2 court cases on record: 2 filed by Nordic Pharmaceuticals. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Gracure Pharmaceuticals Ltd. | Disposed |
| High Court, UTTARPRADESH | Court case (COMP) | Filed by the company against Alpha Pharmaceuticals and Another | Disposed |
To see the full case history of Nordic Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Nordic Pharmaceuticals Limited has 2 MSME Form 1 returns on record between 2021 and 2022, listing 3 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| M/S Insight Softlabz | |||
| Ultra Drugs Private Limited |
To see the full MSME payment records of Nordic Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Nordic Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCN3948D1ZG | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nordic Pharmaceuticals Limited, buy the company report.
Recent activity
Nordic Pharmaceuticals Limited has 5 board changes on record since 1997: 4 appointments and 1 cessation. The latest: Santosh Poddar ceased to be Director on 11 Oct 2022.
AGM
Nordic Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Nordic Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Santosh Poddar ceased to be Director.
Charges
A charge with Bank Of India of Rs. 40.00 Lakh registered on 01 Feb 1999 with Charge ID 90035047 was modified on 08 Mar 2019.
Appointed
Kusum Poddar was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 6.99 Lakh with Charge ID 10510423 was registered on 26 Jun 2014.
Charges
A charge with Bank Of India amounted to Rs. 40.00 Lakh with Charge ID 90035047 was registered on 01 Feb 1999.
Appointed
Banwari Lal Poddar was appointed as Director.
Appointed
Manish Poddar was appointed as Director.
Appointed
Manoj Kumar Poddar was appointed as Director.
Incorporation
16 Sep 1997
Nordic Pharmaceuticals Limited was registered on 16 Sep 1997 with Roc Delhi Ii & aged 29 years 1 month as per MCA records.
Frequently asked questions
Nordic Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 September 1997 (29+ years old) and is registered under CIN U24231DL1997PLC089698.
Nordic Pharmaceuticals has 4 current directors:
- Kusum Poddar - Director
- Banwari Lal Poddar - Director
- Manoj Kumar Poddar - Director
- Manish Poddar - Director
The latest financial statements of Nordic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nordic Pharmaceuticals is 09AACCN3948D1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nordic Pharmaceuticals is U24231DL1997PLC089698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nordic Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Nordic Pharmaceuticals was incorporated on 16 September 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nordic Pharmaceuticals by revenue are Mandlive Healthcare Private Limited, Rachit Remedies Private Limited, B2s Pharma Private Limited, Levitas Pharmaceuticals Private Limited, HP Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Santosh Poddar ceased to be Director on 11 Oct 2022. Kusum Poddar was appointed as Director on 30 Mar 2015. Banwari Lal Poddar was appointed as Director on 16 Sep 1997. Nordic Pharmaceuticals has 5 board changes on record in total.
Yes, Nordic Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0022076).
Nordic Pharmaceuticals has 2 MSME Form 1 returns on record between 2021 and 2022, listing 3 overdue payments to 2 micro and small suppliers. The latest return was filed on 15 Sep 2022.
Nordic Pharmaceuticals can be reached through the website nordicpharmagroup.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages